Find Doxapram Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

3 RELATED EXCIPIENT COMPANIES

4EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 113-07-5, Stimulexin, Dopram, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride, Doxapram hydrochloride anhydrous, Doxapram (hydrochloride)
Molecular Formula
C24H31ClN2O2
Molecular Weight
415.0  g/mol
InChI Key
MBGXILHMHYLZJT-UHFFFAOYSA-N
FDA UNII
FB8713U6DM

Doxapram Hydrochloride
A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
1 2D Structure

Doxapram Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrochloride
2.1.2 InChI
InChI=1S/C24H30N2O2.ClH/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;/h3-12,22H,2,13-19H2,1H3;1H
2.1.3 InChI Key
MBGXILHMHYLZJT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4.Cl
2.2 Other Identifiers
2.2.1 UNII
FB8713U6DM
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Docatone

2. Dopram

3. Doxapram

4. Hydrochloride, Doxapram

2.3.2 Depositor-Supplied Synonyms

1. 113-07-5

2. Stimulexin

3. Dopram

4. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Monohydrochloride

5. Doxapram Hydrochloride Anhydrous

6. Doxapram (hydrochloride)

7. Fb8713u6dm

8. 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrochloride

9. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride

10. Dsstox_cid_27815

11. Dsstox_rid_82579

12. Dsstox_gsid_47837

13. Doxapramhydrochloride

14. Chebi:59837

15. Ahr-619

16. Cas-113-07-5

17. 3,3-diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone Hydrochloride

18. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Hydrochloride Hydrate

19. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride, Monohydrate

20. Ncgc00167459-01

21. Unii-fb8713u6dm

22. Einecs 204-022-3

23. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride

24. Schembl40645

25. Mls001424142

26. Chembl1200876

27. Dtxsid9047837

28. Tox21_112463

29. Mfcd00072148

30. Nsc170958

31. Akos015906444

32. Tox21_112463_1

33. Ac-4694

34. Ccg-101076

35. Ccg-221205

36. Nc00326

37. Nsc 170958

38. Sb18933

39. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride

40. Ncgc00167459-02

41. As-13336

42. Smr000469229

43. 2-pyrrolidinone,3-diphenyl-, Monohydrochloride

44. 081d530

45. 113d075

46. J-002892

47. Q27126918

48. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Hydrochloride

49. (+/-)-1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Monohydrochloride

50. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Hydrochloride, Hydrate (1:1:1)

51. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride, (+/-)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 415.0 g/mol
Molecular Formula C24H31ClN2O2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count6
Exact Mass414.2074059 g/mol
Monoisotopic Mass414.2074059 g/mol
Topological Polar Surface Area32.8 Ų
Heavy Atom Count29
Formal Charge0
Complexity487
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameDoxapram hydrochloride
Drug LabelDOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP ....................................
Active IngredientDoxapram hydrochloride
Dosage FormInjectable
RouteInjection
Strength20mg/ml
Market StatusPrescription
CompanyBedford

2 of 2  
Drug NameDoxapram hydrochloride
Drug LabelDOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP ....................................
Active IngredientDoxapram hydrochloride
Dosage FormInjectable
RouteInjection
Strength20mg/ml
Market StatusPrescription
CompanyBedford

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Central Nervous System Stimulants

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)


Respiratory System Agents

Drugs used for their effects on the respiratory system. (See all compounds classified as Respiratory System Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Respiratory Stimulant [EPC]; Increased Medullary Respiratory Drive [PE]

API SUPPLIERS

read-more
read-more

01

Midas Pharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
Midas Pharma

02

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

03

ALP Pharm

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

ALP Pharm

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Boehringer Ingelheim GmbH

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Boehringer Ingelheim GmbH

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF Inactive-api CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

05

Catalytica

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Catalytica

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

DMFs Not Supported

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

DMFs Not Supported

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Synergene Active Ingredients Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Synergene Active Ingredients Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Xian Libang Pharmaceutical Co.,Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Xian Libang Pharmaceutical Co.,Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Khandelwal Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Khandelwal Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

10

Arevipharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Arevipharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2018-06-11

Pay. Date : 2018-01-26

DMF Number : 32049

Submission : 2018-01-26

Status : Active

Type : II

Midas Pharma

02

Medlab Asia & Asia Health
Not Confirmed

03

Medlab Asia & Asia Health
Not Confirmed

03

Medlab Asia & Asia Health
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6114

Submission : 1985-12-02

Status : Inactive

Type : II

blank

04

Medlab Asia & Asia Health
Not Confirmed

04

Medlab Asia & Asia Health
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 7183

Submission : 1987-10-14

Status : Inactive

Type : II

blank

05

Sb Penick And Co

Country

USDMF

arrow
Medlab Asia & Asia Health
Not Confirmed

05

Sb Penick And Co

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 573

Submission : 1963-06-03

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content
R1-CEP 2017-084 - Rev 00
Valid
Chemical
2023-07-17
1201
Midas Pharma

01

arrow
CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content

Certificate Number : R1-CEP 2017-084 - Rev 00

Status : Valid

Issue Date : 2023-07-17

Type : Chemical

Substance Number : 1201

Midas Pharma
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram hydrochloride

Registration Number : 218MF10495

Registrant's Address : 2820 North Normandy Drive Petersburg, Virginia 23805

Initial Date of Registration : 2006-05-15

Latest Date of Registration : 2010-03-25

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram (EP)

Date of Issue : 2013-08-08

Valid Till : 2016-07-02

Written Confirmation Number : WC-0223

Address of the Firm : Plot B-1 Wagle Industrial Eastate Thane W 400604 Maharashtra State

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

DOXAPRAM HYDROCHLORIDE

NDC Package Code : 10920-601

Start Marketing Date : 2017-10-25

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Midas Pharma

Germany
arrow
CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content

Doxapram Hydrochloride

About the Company : Midas Pharma is a pharmaceutical company that excels in providing extensive expertise while fostering connections between companies, individuals, and knowledge. The core competence...

Midas Pharma is a pharmaceutical company that excels in providing extensive expertise while fostering connections between companies, individuals, and knowledge. The core competence of Midas Pharma lies in project management related to pharmaceutical supply chains. The company is actively involved in sourcing, supplying, and developing Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDF) manufactured by its contract manufacturing partners. For each project or product, Midas Pharma selects the most suitable match from its network of manufacturing partners.
Midas Pharma

02

arrow
CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Doxapram

About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.
Jai Radhe Sales

03

Arevipharma

Germany
CPHI Middle east
Not Confirmed
arrow

Arevipharma

Germany
arrow
CPHI Middle east
Not Confirmed

Doxapram Hydrochloride

About the Company : Arevipharma GmbH is a modern manufacturer of active pharmaceutical ingredients and intermediates with more than 140 years of expertise. Our customers are generic and research-based...

Arevipharma GmbH is a modern manufacturer of active pharmaceutical ingredients and intermediates with more than 140 years of expertise. Our customers are generic and research-based pharmaceutical companies on five continents. Our business partners recognise us as a competent, reliable and efficient company that is distinguished by individual service and an innovative character. The company’s 140 year history is based on the knowledge, skills, commitment and loyalty of its employees. Arevipharma also feels committed to its owners and investors. Due to the consistent expansion of new technologies,
blank

04

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram Hydrochloride

About the Company : Gurvey & Berry offers an impressive lineup of bulk raw materials, but we are much more than products by the kilo or tonne. With 4 decades behind us, and our Service First philosoph...

Gurvey & Berry offers an impressive lineup of bulk raw materials, but we are much more than products by the kilo or tonne. With 4 decades behind us, and our Service First philosophy, we can make your ingredient procurement process easy. We’re here to help. From trusted manufacturers around the world, we source and supply about 200 products for our customers in the natural health, pharmaceutical, animal health & nutrition, food and cosmetics industries. Regulatory requirements, special orders, new products… let us help you.
blank

05

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram Hydrochloride

About the Company : Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of ma...

Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of manufacturing CNS drugs in China. The 520,000 m2 production base consists of five GMP workshops, R&D center and testing Lab
blank

06

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram Hydrochloride

About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...

Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharmaceuticals, Nishchem International Pvt. Ltd. (NIPL) stands on the virtue of revolutionizing the ends, as well as the means to safe and secure health. Medicinal drugs have always held an important place in the sphere of healing and treatment, with their applications ranging from diagnosis, treatment and cure right up to prophylaxis.
blank

07

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram HCL

About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...

Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals Ingredients (API'S) for wide range of therapeutic categories. Therapeutic segments of focus are Anti Fungals, Anti Depressants, and Anti Hypertensive. Synergene manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. The company has two manufacturing facilities located at Hyderabad & Vishakhapatnam manufacturing Active Pharmaceutical Ingredients and Intermediates.
blank

08

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

Doxapram HCL

About the Company : Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical ...

Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical products and healthy nutrition products, also presenting in the cultural industry. Libang Group, with Xi’an Libang Holdings Ltd. as the parent company, divided into Libang Pharmaceutical Group, Healthy Nutrition Group and other wholly owned subsidiaries engaged in culture, financial, property etc, totally over 1000 employees.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1613068200,"product":"PHARMACEUTICAL INGREDIENT OF INDIAN ORIG IN(DOXAPRAM HCL USP)","address":"3, BOTAWALA BLDG., 1ST FLOOR, BANK STREET, BEHIND SBI, FORT","city":"MUMBAI","supplier":"NISHCHEM INTERNATIONAL PVT. LTD","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF,","customerCountry":"PAKISTAN","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"13.6","totalValueFC":"2019","currency":"USD","unitRateINR":980,"date":"12-Feb-2021","totalValueINR":"147000","totalValueInUsd":"2019","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8604782","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"3, BOTAWALA BLDG., 1ST FLOOR, BANK STREET, BEHIND SBI, FORT, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1621535400,"product":"PHARMACEUTICAL INGREDIENT OF INDIAN ORIG IN DOXAPRAM HCL EP","address":"3, BOTAWALA BLDG., 1ST FLOOR, BANK STREET, BEHIND SBI, FORT","city":"MUMBAI","supplier":"NISHCHEM INTERNATIONAL PVT. LTD","supplierCountry":"INDIA","foreign_port":"MULHOUSE","customer":"TO THE ORDER OF,","customerCountry":"FRANCE","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"6267","totalValueFC":"24657.7","currency":"USD","unitRateINR":451540.5,"date":"21-May-2021","totalValueINR":"1806162","totalValueInUsd":"24657.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"1904621","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"3, BOTAWALA BLDG., 1ST FLOOR, BANK STREET, BEHIND SBI, FORT, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705948200,"product":"PHARMACEUTICAL RAW MATERIAL BULK DRUGSDOXAPRAM HYDROCHLORIDE","address":"15-206\/1","city":"PUTTUR","supplier":"HONEY DRUGS","supplierCountry":"INDIA","foreign_port":"JOHANNESBURG - JOHAN","customer":"TO THE ORDER OF","customerCountry":"SOUTH AFRICA","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"17","totalValueFC":"2447.4","currency":"USD","unitRateINR":1356.03,"date":"23-Jan-2024","totalValueINR":"203404.5","totalValueInUsd":"2447.4","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"6954222","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SOUTH AFRICA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"15-206\/1, PUTTUR","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722450600,"product":"DOXAPRAM RELATED COMPOUND B (QTY: 1 X 0.45 G, VALUE USD: 489.47) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00045","unit":"KGS","unitRateFc":"1087711","totalValueFC":"505.3","currency":"USD","unitRateINR":"94189177.8","date":"01-Aug-2024","totalValueINR":"42385.13","totalValueInUsd":"505.3","indian_port":"Hyderabad Air","hs_no":"29337990","bill_no":"4826736","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722450600,"product":"DOXAPRAM RELATED COMPOUND B (QTY: 5 X 0.1 G, VALUE USD: 118.88\/EACH) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"1188800","totalValueFC":"613.6","currency":"USD","unitRateINR":"102942880","date":"01-Aug-2024","totalValueINR":"51471.44","totalValueInUsd":"613.6","indian_port":"Hyderabad Air","hs_no":"29337990","bill_no":"4826736","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"}]
12-Feb-2021
01-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

INTERMEDIATES SUPPLIERS

read-more
read-more

01

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 110-52-1

End Use API : Doxapram Hydrochloride

About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Actavis Inc

Ireland
Medlab Asia & Asia Health
Not Confirmed
arrow

Actavis Inc

Ireland
arrow
Medlab Asia & Asia Health
Not Confirmed

DOXAPRAM HYDROCHLORIDE

Brand Name : DOXAPRAM HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 1992-01-30

Application Number : 73529

Regulatory Info : DISCN

Registration Country : USA

blank

02

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

DOXAPRAM HYDROCHLORIDE

Brand Name : DOXAPRAM HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 2003-01-10

Application Number : 76266

Regulatory Info : RX

Registration Country : USA

blank

03

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Doxapram HCL

Brand Name : Dopram Fresenius 20mg/1ml

Dosage Form : INJ

Dosage Strength : 20mg/ml

Packaging : 20X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

04

Hikma Pharmaceuticals

United Kingdom
Medlab Asia & Asia Health
Not Confirmed
arrow

Hikma Pharmaceuticals

United Kingdom
arrow
Medlab Asia & Asia Health
Not Confirmed

DOXAPRAM HYDROCHLORIDE

Brand Name : DOPRAM

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 1982-01-01

Application Number : 14879

Regulatory Info : RX

Registration Country : USA

blank

05

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Doxapram Hydrochloride

Brand Name : Mopram

Dosage Form : INJECTION

Dosage Strength : 100MG/5ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

06

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Doxapram

Brand Name :

Dosage Form : Injection

Dosage Strength : 100MG/5ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank

07

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Doxapram Hydrochloride

Brand Name :

Dosage Form : Injection

Dosage Strength : 100MG

Packaging : 5mL:100mgx4amps

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

read-more
read-more

Parenteral

read-more
read-more

01

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Oral, Topical

Category : Parenteral, Solubilizers, Topical

02

Finar

India
Medlab Asia & Asia Health
Not Confirmed
arrow

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty